About SynchNeuro
SynchNeuro, is researching a novel brain-based, non-invasive cardiometabolic health monitor.
Our discreet behind-the-ear EEG sensor is being studied to analyze brain signals to track glucose levels, sleep quality, stress and activity levels — offering an all-in-one, device to measure and track metabolic health.
Our work began with Dr. Casey Halpern’s research uncovering how brain activity shifts during glucose fluctuations. He identified a strong correlation between EEG patterns and glucose changes, his team made it possible to predict glucose levels using brain signal data. Building on these insights, SynchNeuro is applying advanced machine-learning models to develop a device to deliver accurate, real-time cardiometabolic health information.
SynchNeuro is focused on developing continuous, non-invasive cardiometabolic
health monitoring devices that are accessible and practical, to assist individuals taking control of their metabolic health.
Team
Minds Behind the Innovation
CLINICAL ADVISORS
Barry Cheskin, MBA
Business Advisor
David Klonoff, MD
Endocrinologist
Alyssa Dominguez, MD
Endocrinologist
Gregory Lund, MD
Endocrinologist
Karmeen Kulkarni, RD, CDCES
Diabetes educator
Leslie Pinkerton, RD, CDCES
Diabetes educator
Investors
our support and trust systems
and many family offices & angel investors who resonate with our mission
press
media recognition
waitlist
Be among the first to read the brain signal
Join the waitlist to be one of the first to try our brain-based, non-invasive cardiometabolic monitor
* All em dashes used on the website are human generated.
Investigational device. Limited by Federal (or United States) law to investigational use.
© 2026 SynchNeuro. All rights reserved.
About SynchNeuro
SynchNeuro, is researching a novel brain-based, non-invasive cardiometabolic health monitor.
Our discreet behind-the-ear EEG sensor is being studied to analyze brain signals to track glucose levels, sleep quality, stress and activity levels — offering an all-in-one, device to measure and track metabolic health.
Our work began with Dr. Casey Halpern’s research uncovering how brain activity shifts during glucose fluctuations. He identified a strong correlation between EEG patterns and glucose changes, his team made it possible to predict glucose levels using brain signal data. Building on these insights, SynchNeuro is applying advanced machine-learning models to develop a device to deliver accurate, real-time cardiometabolic health information.
SynchNeuro is focused on developing continuous, non-invasive cardiometabolic
health monitoring devices that are accessible and practical, to assist individuals taking control of their metabolic health.
Team
Minds Behind the Innovation
CLINICAL ADVISORS
Barry Cheskin, MBA
Business Advisor
David Klonoff, MD
Endocrinologist
Alyssa Dominguez, MD
Endocrinologist
Gregory Lund, MD
Endocrinologist
Karmeen Kulkarni, RD, CDCES
Diabetes educator
Leslie Pinkerton, RD, CDCES
Diabetes educator
Investors
our support and trust systems
and many family offices & angel investors who resonate with our mission
press
media recognition
waitlist
Be among the first to read the brain signal
Join the waitlist to be one of the first to try our brain-based, non-invasive cardiometabolic monitor
* All em dashes used on the website are human generated.
Investigational device. Limited by Federal (or United States) law to investigational use.
© 2026 SynchNeuro. All rights reserved.
About SynchNeuro
SynchNeuro, is researching a novel brain-based, non-invasive cardiometabolic health monitor.
Our discreet behind-the-ear EEG sensor is being studied to analyze brain signals to track glucose levels, sleep quality, stress and activity levels — offering an all-in-one, device to measure and track metabolic health.
Our work began with Dr. Casey Halpern’s research uncovering how brain activity shifts during
glucose fluctuations. He identified a strong correlation between EEG patterns and glucose
changes, his team made it possible to predict glucose levels using brain signal data. Building
on these insights, SynchNeuro is applying advanced machine-learning models to develop a
device to deliver accurate, real-time cardiometabolic health information.
SynchNeuro is focused on developing continuous, non-invasive cardiometabolic health monitoring devices that are accessible and practical, to assist individuals taking control of their metabolic health.
Team
Minds Behind the Innovation
CLINICAL ADVISORS
Barry Cheskin, MBA
Business Advisor
David Klonoff, MD
Endocrinologist
Alyssa Dominguez, MD
Endocrinologist
Gregory Lund, MD
Endocrinologist
Karmeen Kulkarni, RD, CDCES
Diabetes educator
Leslie Pinkerton, RD, CDCES
Diabetes educator
Investors
our support and trust systems
and many family offices & angel investors who resonate with our mission
press
media recognition
waitlist
Be among the first to read the brain signal
Join the waitlist to be one of the first to try our brain-based, non-invasive cardiometabolic monitor
* All em dashes used on the website are human generated.
Investigational device. Limited by Federal (or United States) law to investigational use.
© 2026 SynchNeuro. All rights reserved.
